University of Pittsburgh Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2018

  1. Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial

    Journal of Clinical Oncology